Tag: Committee for Medicinal Products for Human Use
July 26, 2019
Theratechnologies Receives Positive Recommendation From the CHMP for Trogarzo® in the European Union
Theratechnologies (TSX:TH) has announced that the Committee for Medicinal Products for Human use has given a positive recommendation for approval... January 15, 2019
European Medicines Agency validates Oasmia Pharmaceutical AB’s application to add efficacy data to the approved Apealea
Oasmia Pharmaceutical AB (NASDAQ:OASM) AB today announce that the European Medicines Agency (EMA) has validated a type II variation application... October 19, 2018
Shire: CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks
Shire (LSE:SHP, NASDAQ:SHPG), the leading global biotechnology company focused on rare diseases, announced today that the European Medicines Agency’s (EMA)... June 29, 2018
European CHMP Adopts Positive Opinion for Yescarta (axicabtagene ciloleucel)
Kite, a Gilead Company (Nasdaq:GILD), announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP)... June 29, 2018
Bristol-Myers Squibb Receives Positive CHMP Opinion Recommending Approval of Opdivo (nivolumab)
Bristol-Myers Squibb (NYSE:BMY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has... June 29, 2018
Puma Biotechnology Receives Positive CHMP Opinion Recommending Approval of NERLYNX
Puma Biotechnology (Nasdaq:PBYI) announced that on June 28, 2018 the Committee for Medicinal Products for Human Use (CHMP) adopted a...
June 26, 2018